Combining Erythropoietin Infusion With Intramyocardial Delivery of Bone Marrow Cells Is More Effective for Cardiac Repair
Document Type
Article
Publication Date
2-1-2007
Description
We postulated that combining erythropoietin (EPO) infusion with bone marrow mesenchymal stem cells (MSC) delivery may give better prognosis in a rat infarcted heart. Acute myocardial infarction (MI) model was developed by coronary artery ligation. Animals were grouped (n = 18) to receive intramyocardial injection of 30 μl saline solution without cells (EPO and control groups) or with 3 × 106 MSC from transgenic green fluorescent protein (GFP)+ male mice (MSC and MSC-EPO groups). The animals received either 5000 U/kg body weight EPO (EPO and MSC-EPO groups) or saline solution (MSC and control groups) for 7 days after MI. Cardiac functions were measured by echocardiography and cardiac tissue was harvested for immunohistological studies 3 weeks after surgery. We observed regeneration of MSC in and around the infarcted myocardium in MSC and MSC-EPO groups. Capillary density was markedly enhanced with significantly smaller infarct size and reduced fibrotic area in MSC-EPO group as compared with other three groups. A smaller left ventricular (LV) diastolic dimension and a higher LV fractional shortening were observed in MSC-EPO group than in other three groups. Transplantation of MSC combined with cytokine EPO is superior to either of the monotherapy approach for angiomyogenesis and cardiac function recovery.
Citation Information
Zhang, Dingguo; Zhang, Fumin; Zhang, Yuqing; Gao, Xiang; Li, Chuanfu; Yang, Naiquan; and Cao, Kejiang. 2007. Combining Erythropoietin Infusion With Intramyocardial Delivery of Bone Marrow Cells Is More Effective for Cardiac Repair. Transplant International. Vol.20(2). 174-183. https://doi.org/10.1111/j.1432-2277.2006.00407.x PMID: 17239026 ISSN: 0934-0874